These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9457037

  • 21. Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients.
    Babel N, Schwarzmann F, Pruss A, Volk HD, Reinke P.
    Transplant Proc; 2004 Nov; 36(9):2679-82. PubMed ID: 15621122
    [Abstract] [Full Text] [Related]

  • 22. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 23. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
    Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP, Burke TG, Ranjan D.
    Int J Pharm; 2009 Jan 21; 366(1-2):133-9. PubMed ID: 18840516
    [Abstract] [Full Text] [Related]

  • 24. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
    Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 02; 88(44):3123-6. PubMed ID: 19159594
    [Abstract] [Full Text] [Related]

  • 25. Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.
    Chen C, Reddy KS, Johnston TD, Khan TT, Ranjan D.
    J Surg Res; 2003 Aug 02; 113(2):228-33. PubMed ID: 12957134
    [Abstract] [Full Text] [Related]

  • 26. NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab.
    Markasz L, Vanherberghen B, Flaberg E, Otvös R, Stuber G, Gustafsson Jernberg A, Olah E, Skribek H, Szekely L.
    Biomed Pharmacother; 2009 Jul 02; 63(6):413-20. PubMed ID: 18834693
    [Abstract] [Full Text] [Related]

  • 27. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
    Jian SW, Mei CE, Liang YN, Li D, Chen QL, Luo HL, Li YQ, Cai TY.
    Ai Zheng; 2003 Jan 02; 22(1):26-9. PubMed ID: 12561431
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 02; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 29. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M, Tahara H, Ide T, Furuichi Y.
    Cancer Res; 2004 May 15; 64(10):3361-4. PubMed ID: 15150084
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants.
    Chen C, Jeon H, Johnston TD, Gedaly R, McHugh PP, Ranjan D.
    J Invest Surg; 2008 May 15; 21(4):201-8. PubMed ID: 18615317
    [Abstract] [Full Text] [Related]

  • 31. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME, Kenney JL, Reiss M, Lacy J.
    Cancer Res; 2000 Oct 01; 60(19):5354-8. PubMed ID: 11034070
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
    Lelièvre JD, Sacre K, Adle-Biassette H, Molinier-Frenkel V, Gaulard P, Papo T.
    J Am Acad Dermatol; 2005 Feb 20; 52(2 Suppl 1):24-7. PubMed ID: 15692507
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 20; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 39. Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal.
    Ranjan D, Chen C, Johnston TD, Jeon H, Ibrahim M, Drake J, Butterfield DA.
    Cell Biochem Funct; 2006 Oct 20; 24(2):147-52. PubMed ID: 15651079
    [Abstract] [Full Text] [Related]

  • 40. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
    Beatty PR, Krams SM, Esquivel CO, Martinez OM.
    Transplantation; 1998 May 15; 65(9):1248-55. PubMed ID: 9603175
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.